Nutri Pharmaceuticals Research Inc.'s 3 OmegasT Fatty Acid to Debut at Food International Asia.

BANGKOK, Thailand -- Nutri Pharmaceuticals Research Inc. (NRIP.PK) announced the launch of 3 OmegasT, a unique essential fatty acid (EFA) formulation. The EFAs in 3 OmegasT are important in maintaining a healthy cardiovascular system.

According to Don Rader, chief research scientist, "3 OmegasT contains a unique combination of EFAs, essential in maintaining a healthy heart and circulatory system and in maintaining normal blood glucose and cholesterol levels." He added, "3 OmegasT offers a rich supply of omega 3, 6 and 9, three of the fatty acids most commonly associated with these health issues."

Available in bulk oil and free-flowing 80-mesh powder, the bulk oil is packed in 180kg drums and the powder is shipped in 25kg cartons.

The 3 OmegaT Powder utilizes NPRI's proprietary O2PT Oil-to-Powder process. Rader stated that the O2PT process converts most edible oils, gels or pastes into a free-flowing, 80-mesh powder while preserving the nutritional value and chemical structure of the base material. The O2PT process does not rely on traditional techniques that utilize heat (spray-drying), micro-encapsulation or freeze-drying. This facilitates food supplement and nutrient marketing companies creating functional foods and nutraceuticals by adding antioxidants, specific EFAs, or other fatty acids such as EPA, CLA, GLA or DHA.

Nutri Pharmaceuticals Research Inc. provides a wide range of powdered oils for functional food, food supplement, cosmetic and pet food applications. The Nutrition Business Journal has awarded the Product Merit Award The O2PT process. The company currently offers more than 40 shelf-stable powders. The company can also apply O2PT powderization to third-party's oil, paste or gel through an arrangement called tolling.

Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pink Sheets" under the symbol NRIP.PK.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.

Additional product technology information may be found at the Web site: www.nprionline.com or http://www.o2p.us.